Literature DB >> 4192382

Viruses in the treatment of cancer.

H E Webb, C E Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4192382     DOI: 10.1016/s0140-6736(70)91790-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Replication-selective microbiological agents: fighting cancer with targeted germ warfare.

Authors:  D H Kirn
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines.

Authors:  Zsolt Fábián; Christine M Csatary; József Szeberényi; Laszlo K Csatary
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Morphological and biological characteristics of the M-P strain of lymphocytic choriomeningitis virus.

Authors:  A Ofodile; M Padnos; N Molomut; J L Duffy
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

4.  Induction of active immune state by multinucleate tumour cells in mice.

Authors:  S K Liao; D H Carr
Journal:  Experientia       Date:  1973-05-15

5.  The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity.

Authors:  S Greiner; J Y Humrich; P Thuman; B Sauter; G Schuler; L Jenne
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer.

Authors:  Sanjay Goel; Allyson J Ocean; Ruwan Y Parakrama; Mohammad H Ghalib; Imran Chaudhary; Umang Shah; Sengottuvel Viswanathan; Himanshu Kharkwal; Matthew Coffey; Radhashree Maitra
Journal:  Mol Cancer Ther       Date:  2020-03-10       Impact factor: 6.261

Review 9.  Conditionally replicating adenoviruses for cancer treatment.

Authors:  Youssef Jounaidi; Joshua C Doloff; David J Waxman
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

10.  Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.

Authors:  Gila Kazimirsky; Wei Jiang; Shimon Slavin; Amotz Ziv-Av; Chaya Brodie
Journal:  Stem Cell Res Ther       Date:  2016-10-10       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.